Sec Form 4 Filing - KUNG ROBERT T V @ ABIOMED INC - 2007-05-30

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person KUNG ROBERT T V 2. Issuer Name and Ticker or Trading Symbol ABIOMED INC [ ABMD] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) SVP, Chief Scientific Officer (Last) (First) (Middle) C/O ABIOMED, INC., 22 CHERRY HILL DRIVE 3. Date of Earliest Transaction (MM/DD/YY) 05/30/2007 (Street) DANVERS, MA01923 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock, $.01 par value 87,060 I By Trust Common Stock, $.01 par value 16,968 I By Trust Common Stock, $.01 par value 100,200 I By Trust ( 9 ) ( 10 ) Common Stock, $.01 par value 05/30/2007 A 4,000 ( 13 ) A $ 0 4,000 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Option (right to buy) ( 1 ) $ 6.813 07/01/2003( 4 ) 07/01/2008 Common Stock 40,000 40,000 D Stock Option (right to buy) ( 2 ) $ 6.688 07/01/2001( 5 ) 07/01/2009 Common Stock 20,000 20,000 D Stock Option (right to buy) ( 2 ) $ 15.563 06/28/2002( 6 ) 06/28/2010 Common Stock 40,000 40,000 D Stock Option (right to buy) ( 3 ) $ 24.12 06/22/2003( 7 ) 06/22/2011 Common Stock 20,000 20,000 D Stock Option (right to buy) ( 3 ) $ 6.75 06/25/2004( 8 ) 06/25/2012 Common Stock 50,000 50,000 D Stock Option (right to buy) ( 2 ) $ 5.11 06/25/2005( 11 ) 06/25/2013 Common Stock 16,000 16,000 D Stock Option (right to buy) ( 3 ) $ 12.3 07/01/2005( 12 ) 07/01/2014 Common Stock 20,000 20,000 D Stock Option (right to buy) ( 3 ) $ 9.36 06/08/2006( 12 ) 06/08/2015 Common Stock 20,000 20,000 D Stock Option (right to buy) ( 3 ) $ 13.57 06/01/2007( 12 ) 06/01/2016 Common Stock 20,000 20,000 D Stock Option (right to buy) ( 3 ) $ 11.27 05/30/2007 A 4,000 05/30/2008( 12 ) 05/30/2017 Common Stock 4,000 $ 11.27 4,000 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other KUNG ROBERT T V C/O ABIOMED, INC. 22 CHERRY HILL DRIVE DANVERS, MA01923 SVP, Chief Scientific Officer Signatures /s/ Carrie-Ann Powierza (by power of attorney) 06/01/2007 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Grant to reporting person of option to buy number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 1992 Combination Stock Option Plan. ( 2 )Grant to reporting person of option to buy number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 1998 Equity Incentive Plan. ( 3 )Grant to reporting person of option to buy number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2000 Stock Incentive Plan. ( 4 )Options were fully exercisable on the date shown. ( 5 )Thirty percent of this option will become exercisable on each of 7/1/01 and 7/1/02 and an addtional 40 percent will become exercisable on 7/1/03 ( 6 )Thirty percent of this option will become exercisable on each of 6/28/02 and 6/28/03 and an addtional 40 percent will become exercisable on 6/28/04. ( 7 )Thirty percent of this option will become exercisable on each of 6/22/03 and 6/22/04 and an addtional 40 percent will become exercisable on 6/22/05. ( 8 )Thirty percent of this option will become exercisable on each of 6/25/04 and 6/25/05 and an addtional 40 percent will become exercisable on 6/25/06. ( 9 )The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for the purposes of Section 16 or for any other purposes. ( 10 )These shares are held in trust for the benefit of the reporting person's spouse. ( 11 )Thirty percent of this option will become exercisable on each of 6/25/05 and 6/25/06 and an addtional 40 percent will become exercisable on 6/25/07. ( 12 )These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6. ( 13 )Shares of restricted stock awarded to reporting person under the ABIOMED, Inc. 2000 Stock Incentive Plan. 100% of these shares vest on the third anniversary of the date of award.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.